Phase II Follow-up trial for Rituximab Interferon Transplant trial: Study Drug-Rituximab, Interferon
A previous phase II trial entitled Treatment of low grade lymphoma with high dose therapy and stem cell support followed by consolidative immunotherapy with Rituximab and interferon-α was conducted at OCC between 2005 and 2012. The primary objectives of this previous trial was to assess progression free survival and overall survival. Of the 36 patients in this trial, approximately 18 remain in remission. In this new follow up trial, follow up data will prospectively be collected on patients who provide informed consent to do so.
The objectives of this trial are to:
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society